GenrAb

Seed
genrab.com Biotech & Healthcare
Total Funding $5.6M
Latest Round $5.6M Seed
Last Announced Apr 22, 2025
Investors Undisclosed
Decision Makers Profile Active

About GenrAb

GenrAb is harnessing the power of innate human immunity to develop therapies that can protect and treat patients with neurological diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website genrab.com
Domain Registered Date Oct 10, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $5,600,000 · Seed

    startupintros.com

  2. Milestone

    Website domain registered

    genrab.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for GenrAb.

Funding History

1 Round
Seed · Apr 22, 2025

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts